Similar companies
| Company | Linkedin Employees | |
|---|---|---|
 |
AmgenAMGN |
41,827 |
 |
Gilead SciencesGILD |
14,851 |
 |
Inovio PharmaceuticalsINO |
201 |
 |
BridgeBio PharmaBBIO |
1,064 |
 |
Crispr TherapeuticsCRSP |
339 |
How Many Employees Does NeuroSense Therapeutics Have?
NeuroSense Therapeutics (NRSN) has 26 employees according to LinkedIn, down 7.1% over the past three months. A shrinking workforce can indicate layoffs, restructuring, or cost-cutting, and headcount declines often precede revenue deceleration. The LinkedIn count includes everyone who lists NeuroSense Therapeutics as their current employer, so it reflects workforce changes sooner than the 16 reported in NeuroSense Therapeutics’s most recent official filing.
With 26 employees, NeuroSense Therapeutics has a smaller workforce than industry peers like Amgen (41,827) and Gilead Sciences (14,851).
Is NeuroSense Therapeutics Growing or Shrinking?
Employee count is one of the most reliable leading indicators in alternative data: companies tend to hire before they grow and cut before they report weakness. AltIndex feeds NeuroSense Therapeutics’s headcount into the NRSN AI Score alongside job postings, employee business outlook, and 20+ other signals.
For more on NeuroSense Therapeutics’s workforce, see its job postings, employee business outlook, and employee ratings. For a demand-side read, see NeuroSense Therapeutics web traffic.
Month over Month
| Sep 2026 | 26 | |
| Aug 2026 | 28 | |
| Jul 2026 | 28 | |
| Jun 2026 | 28 | |
| May 2026 | 29 |
NeuroSense Therapeutics Employees & Headcount: Frequently Asked Questions
NeuroSense Therapeutics has 26 employees according to LinkedIn, compared with 16 reported in its most recent official filings. The LinkedIn figure counts everyone who lists NeuroSense Therapeutics as their current employer, so it reflects workforce changes sooner than annual filings.
NeuroSense Therapeutics’s headcount has declined 7.1% over three months, suggesting layoffs or natural attrition without backfilling. View the headcount trend chart above for the full history.
Headcount is a leading indicator: companies typically hire before revenue accelerates and reduce staff before earnings disappoint. No single data point predicts a stock on its own, which is why AltIndex combines NeuroSense Therapeutics’s headcount with job postings, employee business outlook, and 20+ other signals in its AI Score.
NeuroSense Therapeutics underperforms its industry peers when it comes to Linkedin Employees, ranking dead last.
Sign up and get more insights on NeuroSense Therapeutics.
See NeuroSense Therapeutics’s complete linkedin employees history
Sign up to unlock 1-year and all-time charts for NRSN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
